Lannett Expands Strategic Relationship To Include Biosimilar Fast-Acting Insulin

Author's Avatar
Feb 09, 2021
Article's Main Image

--Lannett and HEC to Co-develop Insulin Aspart; Lannett Granted Exclusive US Commercialization Rights--

PR Newswire